<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urmj</journal-id><journal-title-group><journal-title xml:lang="ru">Уральский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Ural Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-4389</issn><publisher><publisher-name>Ural State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52420/umj.23.3.98</article-id><article-id custom-type="edn" pub-id-type="custom">QSFNEE</article-id><article-id custom-type="elpub" pub-id-type="custom">urmj-1539</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клинические случаи | Clinical cases</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical cases</subject></subj-group></article-categories><title-group><article-title>Первичная кожная диффузная B‑крупноклеточная лимфома, тип «нижних конечностей»: клинический случай</article-title><trans-title-group xml:lang="en"><trans-title>Primary Cutaneous Diffuse Large B‑Cell Lymphoma, Leg Type: A Clinical Case</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-2902-0432</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зимников</surname><given-names>Г. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Zimnikov</surname><given-names>G. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Георгий Эдуардович Зимников — ординатор кафедры онкологии и радиационной медицины с курсом медицинской физики Медико-биологического университета инноваций и непрерывного образования</p><p>Москва</p></bio><bio xml:lang="en"><p>Georgij E. Zimnikov — Resident of the Department of Oncology and Radiation Medicine with a Course of Medical Physics of the Medico-Biological University of Innovation and Continuing Education</p><p>Moscow</p></bio><email xlink:type="simple">zimnikov.egor@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5391-6843</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аксененко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Aksenenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аркадий Владимирович Аксененко — кандидат медицинских наук, врач-онколог Онкологического центра</p><p>Москва</p></bio><bio xml:lang="en"><p>Arkadij V. Aksenenko — Candidate of Sciences (Medicine), Oncologist of the Oncology Center</p><p>Moscow</p></bio><email xlink:type="simple">micsurg@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1825-1871</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Завьялов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zavialov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александр Александрович Завьялов — доктор медицинских наук, профессор, руководитель Онкологического центра</p><p>Москва</p></bio><bio xml:lang="en"><p>Aleksandr A. Zavialov — Doctor of Sciences (Medicine), Professor, Head of the Oncology Center</p><p>Moscow</p></bio><email xlink:type="simple">azav06@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственный научный центр — Федеральный медицинский биофизический центр имени А. И. Бурназяна ФМБА России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State Research Center — Burnasyan Federal Medical Biophysical Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>12</day><month>07</month><year>2024</year></pub-date><volume>23</volume><issue>3</issue><fpage>98</fpage><lpage>107</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зимников Г.Э., Аксененко А.В., Завьялов А.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Зимников Г.Э., Аксененко А.В., Завьялов А.А.</copyright-holder><copyright-holder xml:lang="en">Zimnikov G.E., Aksenenko A.V., Zavialov A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.umjusmu.ru/jour/article/view/1539">https://www.umjusmu.ru/jour/article/view/1539</self-uri><abstract><sec><title>Введение</title><p>Введение. Первичная кожная диффузная В-крупноклеточная лимфома, тип «нижних конечностей», — редкий вариант лимфомы кожи, который характеризуется агрессивным течением, высоким риском внекожных проявлений и требует проведения высокодозной химиотерапии, а также появлением опухолевых узлов, в подавляющем большинстве случаев локализующихся на коже нижних конечностей.</p><p>Цель работы — ознакомить широкий круг специалистов с особенностями клинических проявлений редкого заболевания, первичной кожной диффузной В-крупноклеточной лимфомы.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Представлен клинический случай, проанализирована история заболевания пациента с индолентным течением и кожными проявлениями В-крупноклеточной лимфомы.</p></sec><sec><title>Результаты</title><p>Результаты. Проведена дифференциальная диагностика заболевания. Установлен заключительный клинический диагноз на основании данных патоморфологического и иммуногистохимического исследования материала, определена тактика дальнейшего лечения.</p></sec><sec><title>Обсуждение</title><p>Обсуждение. У пациента единственным начальным клиническим симптомом являлось наличие пятен и бляшек, без дополнительных проявлений заболевания. Самопроизвольный регресс поражений кожи (исчезновение пятен и бляшек) предполагает благоприятный прогноз и указывает нам на индолентный характер процесса. Очевидно, что выбор тактики диагностических мероприятий в подобных случаях определяется не только сбором анамнеза, оценкой локального статуса, но и проведением эксцизионной биопсии на первом этапе обследования больного для правильной и своевременной постановки диагноза.</p></sec><sec><title>Заключение</title><p>Заключение. В связи с редкостью указанного подтипа лимфомы, а также малым количеством российских публикаций по представленной тематике более глубокое изучение и описание каждого клинического случая приводит к расширению наших представлений об особенностях симптоматики и течения заболевания, процессах патологических изменений в клетках, тканях и органах. Это, возможно, приведет к разработке более эффективных методов ранней диагностики и своевременного лечения рассматриваемого заболевания.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type it is a rare variant of skin lymphoma that has an aggressive course and a high risk of extracutaneous manifestations.</p><p>The purpose of this work is to familiarize a wide range of specialists with the clinical manifestations of a rare disease — primary cutaneous diffuse large B-cell lymphoma.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. An interesting clinical case is presented and the medical history of a patient with B-cell lymphoma from the skin is analyzed.</p></sec><sec><title>Results</title><p>Results. A differential diagnosis of the disease was made. Based on the study of histological material, the final clinical diagnosis was established and further treatment tactics were determined.</p></sec><sec><title>Discussion</title><p>Discussion. The patient had spots and plaques on the lower extremities, the sole visible signs of the disease. These symptoms may suggest a positive prognosis and a gradual progression. Diagnostic measures should include gathering medical history, assessing the local condition, and carrying out an excision biopsy early in the examination process for an accurate and prompt diagnosis</p></sec><sec><title>Conclusion</title><p>Conclusion. Due to the rarity of this subtype of lymphoma and the limited number of domestic publications on the topic, a more detailed study and description of individual clinical cases can lead to a better understanding of the characteristics of the symptoms and the processes of pathological changes in cells, tissues, and organs. This could potentially lead to the development of more efficient methods for early diagnosis and timely treatment of the condition.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>диффузная В-крупноклеточная лимфома</kwd><kwd>особенности первичной диагностики</kwd><kwd>химиотерапия</kwd><kwd>поражения кожи</kwd></kwd-group><kwd-group xml:lang="en"><kwd>DLBCL</kwd><kwd>chemotherapy</kwd><kwd>features of primary diagnosis</kwd><kwd>skin lesions</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Grandi V, Alberti Violetti S, La Selva R, Cicchelli S, Delfino C, Fava P, et al. Primary cutaneous B-cell lymphoma: Narrative review of the literature. Giornale Italiano di Dermatologia e Venereologia. 2019; 154(4):466–479. DOI: https://doi.org/10.23736/S0392-0488.17.05670-X.</mixed-citation><mixed-citation xml:lang="en">Grandi V, Alberti Violetti S, La Selva R, Cicchelli S, Delfino C, Fava P, et al. Primary cutaneous B-cell lymphoma: Narrative review of the literature. Giornale Italiano di Dermatologia e Venereologia. 2019; 154(4):466–479. DOI: https://doi.org/10.23736/S0392-0488.17.05670-X.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–1714. DOI: https://doi.org/10.1182/blood-2018-11-881268. Erratum in: Blood. 2019;134(13):1112. DOI: https://doi.org/10.1182/blood.2019002852.</mixed-citation><mixed-citation xml:lang="en">Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–1714. DOI: https://doi.org/10.1182/blood-2018-11-881268. Erratum in: Blood. 2019;134(13):1112. DOI: https://doi.org/10.1182/blood.2019002852.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Karakulov RK, Kaydarova DR, Dushimova ZD, Gabbasova ST, Sagindykov GA, Nasipov BA, et al. Differentiated approach in the treatment of diffuse large B-cell lymphoma according to c-MYC and BCL2 status. Oncohematology. 2022;17(1):37–42. (In Russ.). DOI: https://doi.org/10.17650/1818-8346-2022-17-1-37-42.</mixed-citation><mixed-citation xml:lang="en">Karakulov RK, Kaydarova DR, Dushimova ZD, Gabbasova ST, Sagindykov GA, Nasipov BA, et al. Differentiated approach in the treatment of diffuse large B-cell lymphoma according to c-MYC and BCL2 status. Oncohematology. 2022;17(1):37–42. (In Russ.). DOI: https://doi.org/10.17650/1818-8346-2022-17-1-37-42.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tadiotto Cicogna G, Ferranti M, Lazzarotto A, Alaibac M. Biological approaches to aggressive cutaneous B-cell lymphomas. Frontiers in Oncology. 2019;9:1238. DOI: https://doi.org/10.3389/fonc.2019.01238.</mixed-citation><mixed-citation xml:lang="en">Tadiotto Cicogna G, Ferranti M, Lazzarotto A, Alaibac M. Biological approaches to aggressive cutaneous B-cell lymphomas. Frontiers in Oncology. 2019;9:1238. DOI: https://doi.org/10.3389/fonc.2019.01238.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly J, Mirkin G, Yim J, Hao X. Primary cutaneous diffuse large B-cell lymphoma, leg type on the dorsal foot in a senior woman: A case report. Journal of the American Podiatric Medical Association. 2022;112(6):21– 143. DOI: https://doi.org/10.7547/21-143.</mixed-citation><mixed-citation xml:lang="en">Kelly J, Mirkin G, Yim J, Hao X. Primary cutaneous diffuse large B-cell lymphoma, leg type on the dorsal foot in a senior woman: A case report. Journal of the American Podiatric Medical Association. 2022;112(6):21– 143. DOI: https://doi.org/10.7547/21-143.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Penskaya EA, Babaeva FE, Kravchenko SK, Kovrigina AM, Gorenkova LG, Smirnova SYu, et al. Primary cutaneous diffuse B-large cell lymphoma, a type of lower extremity with an atypical clinical picture and indolent course. Russian Journal of Hematology and Transfusiology (Gematologiya i transfuziologiya). 2015;60(4):44–47 (In Russ). EDN: https://elibrary.ru/uyhgjx.</mixed-citation><mixed-citation xml:lang="en">Penskaya EA, Babaeva FE, Kravchenko SK, Kovrigina AM, Gorenkova LG, Smirnova SYu, et al. Primary cutaneous diffuse B-large cell lymphoma, a type of lower extremity with an atypical clinical picture and indolent course. Russian Journal of Hematology and Transfusiology (Gematologiya i transfuziologiya). 2015;60(4):44–47 (In Russ). EDN: https://elibrary.ru/uyhgjx.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Marasca C, Fabbrocini G, Cinelli E, Fontanella G, Marasca D, Zagaria O. A case of a primary cutaneous diffuse large B-cell lymphoma, leg type. International Wound Journal. 2020;17(2):514–515. DOI: https://doi.org/10.1111/iwj.13298.</mixed-citation><mixed-citation xml:lang="en">Marasca C, Fabbrocini G, Cinelli E, Fontanella G, Marasca D, Zagaria O. A case of a primary cutaneous diffuse large B-cell lymphoma, leg type. International Wound Journal. 2020;17(2):514–515. DOI: https://doi.org/10.1111/iwj.13298.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Behera B, Palit A, Nayak AK, Panigrahi A, Mishra P, Sethy M. Clinico-dermoscopic-pathological features of a rare case of locally invasive multifocal primary cutaneous diffuse large B cell lymphoma-leg type over the face and scalp. Indian Journal of Dermatology. 2022;67(3):283–286. DOI: https://doi.org/10.4103/ijd.IJD_783_20.</mixed-citation><mixed-citation xml:lang="en">Behera B, Palit A, Nayak AK, Panigrahi A, Mishra P, Sethy M. Clinico-dermoscopic-pathological features of a rare case of locally invasive multifocal primary cutaneous diffuse large B cell lymphoma-leg type over the face and scalp. Indian Journal of Dermatology. 2022;67(3):283–286. DOI: https://doi.org/10.4103/ijd.IJD_783_20.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Obaidi A, Parker NA, Choucair K, Lalich D, Truong P. Primary cutaneous diffuse large B-cell lymphoma, leg type: A case report. Cureus. 2020;12(6): e8651. DOI: https://doi.org/10.7759/cureus.8651.</mixed-citation><mixed-citation xml:lang="en">Al-Obaidi A, Parker NA, Choucair K, Lalich D, Truong P. Primary cutaneous diffuse large B-cell lymphoma, leg type: A case report. Cureus. 2020;12(6): e8651. DOI: https://doi.org/10.7759/cureus.8651.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wilcox RA. Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management. American Journal of Hematology. 2016;91(10):1052–1055. DOI: https://doi.org/10.1002/ajh.24462.</mixed-citation><mixed-citation xml:lang="en">Wilcox RA. Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management. American Journal of Hematology. 2016;91(10):1052–1055. DOI: https://doi.org/10.1002/ajh.24462.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Papoudou-Bai A, Marinos L, Vassou A, Kapsali E, Kanavaros P. CD5-positive primary cutaneous diffuse large B-cell lymphoma-leg type. Case Reports in Dermatological Medicine. 2019;2019:3730915. DOI: https://doi.org/10.1155/2019/3730915.</mixed-citation><mixed-citation xml:lang="en">Papoudou-Bai A, Marinos L, Vassou A, Kapsali E, Kanavaros P. CD5-positive primary cutaneous diffuse large B-cell lymphoma-leg type. Case Reports in Dermatological Medicine. 2019;2019:3730915. DOI: https://doi.org/10.1155/2019/3730915.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wilcox RA. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology. 2018;93(11):1427–1430. DOI: https://doi.org/10.1002/ajh.25224.</mixed-citation><mixed-citation xml:lang="en">Wilcox RA. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology. 2018;93(11):1427–1430. DOI: https://doi.org/10.1002/ajh.25224.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ryabukhina YE, Abbasbeyli FM, Timofeeva OL, Zeynalova PA, Zhukov AG. Primary cutaneous diffuse large B-cell lymphoma, leg type, in an 80-year-old female patient. Clinical case. MD-Onco. 2022;2(4):34–40. (In Russ.). DOI: https://doi.org/10.17650/2782-3202-2022-2-4-34-40.</mixed-citation><mixed-citation xml:lang="en">Ryabukhina YE, Abbasbeyli FM, Timofeeva OL, Zeynalova PA, Zhukov AG. Primary cutaneous diffuse large B-cell lymphoma, leg type, in an 80-year-old female patient. Clinical case. MD-Onco. 2022;2(4):34–40. (In Russ.). DOI: https://doi.org/10.17650/2782-3202-2022-2-4-34-40.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wang CS, Chu X, Yang D, Ren L, Meng NL, Lv XX, et al. Diffuse large B-cell lymphoma arising from follicular lymphoma with warthin’s tumor of the parotid gland — immunophenotypic and genetic features: A case report. World Journal of Clinical Cases. 2019;7(22):3895–3903. DOI: https://doi.org/10.12998/wjcc.v7.i22.3895.</mixed-citation><mixed-citation xml:lang="en">Wang CS, Chu X, Yang D, Ren L, Meng NL, Lv XX, et al. Diffuse large B-cell lymphoma arising from follicular lymphoma with warthin’s tumor of the parotid gland — immunophenotypic and genetic features: A case report. World Journal of Clinical Cases. 2019;7(22):3895–3903. DOI: https://doi.org/10.12998/wjcc.v7.i22.3895.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Massone C, Fink-Puches R, Wolf I, Zalaudek I, Cerroni L. Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type. Journal of the American Academy of Dermatology. 2015;72(6):1016–1020. DOI: https://doi.org/10.1016/j.jaad.2015.02.1134.</mixed-citation><mixed-citation xml:lang="en">Massone C, Fink-Puches R, Wolf I, Zalaudek I, Cerroni L. Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type. Journal of the American Academy of Dermatology. 2015;72(6):1016–1020. DOI: https://doi.org/10.1016/j.jaad.2015.02.1134.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta P, Shruti S, Siraj F, Bhargava A, Khullar G. Primary cutaneous large B cell lymphoma masquerading as lupus vulgaris. Journal of Cancer Research and Therapeutics. 2023;19(5):1477–1479. DOI: https://doi.org/10.4103/jcrt.jcrt_54_21.</mixed-citation><mixed-citation xml:lang="en">Gupta P, Shruti S, Siraj F, Bhargava A, Khullar G. Primary cutaneous large B cell lymphoma masquerading as lupus vulgaris. Journal of Cancer Research and Therapeutics. 2023;19(5):1477–1479. DOI: https://doi.org/10.4103/jcrt.jcrt_54_21.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kozlov SV, Zaharov VP, Kaganov OI, Moryatov AA, Orlov AE, Bratchenko IA, et al. New technologies for differential non-invasive diagnosis of skin tumors. Malignant Tumors. 2017;(3 Suppl 1):156–157. (In Russ.). EDN: https://elibrary.ru/ymsxxl.</mixed-citation><mixed-citation xml:lang="en">Kozlov SV, Zaharov VP, Kaganov OI, Moryatov AA, Orlov AE, Bratchenko IA, et al. New technologies for differential non-invasive diagnosis of skin tumors. Malignant Tumors. 2017;(3 Suppl 1):156–157. (In Russ.). EDN: https://elibrary.ru/ymsxxl.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
